Novo Nordisk's Innovation Supports a Wide Moat and GLP-1 Market Growth
We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...
Here's why researchers think most people stop taking weight loss drugs within a year
Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...
New class seeks to help air travelers tackle fears
Two deadly plane crashes in one week is ramping up the fear of flying, or aviophobia, amongst some people, but there are ways ...
Zacks Small Cap Research on MSN10d
LEXX: IRB Approval Clears Way for GLP-1 Study #5
LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal first quarter 2025 ...
Ozempic’s health benefits keep growing, but are the risks worth it?
A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications. Experts break down the findings.
Medscape16d
Is There a Link Between Liraglutide and Pancreatitis?
Diabetes Care. 2015;38(6):1058-1066. The safety profile of liraglutide is under continuous surveillance through meticulous routine pharmacovigilance, with any cases of pancreatitis being analyzed ...
studyfinds17d
28 benefits, 16 risks: How popular GLP-1 weight loss drugs reshape human health – for better and worse
Discover the unexpected health benefits of diabetes and weight loss medications like Ozempic and Wegovy. Find out how these ...
Yahoo24d
Public health experts are warning of a ‘quad-demic’ this winter. Here’s where flu, COVID, RSV, and norovirus are spreading
As you dive into your New Year’s resolutions, taking precautions to protect yourself from a quartet of infectious diseases can lessen your odds of starting off 2025 sick. Fact check: $50 million ...
infectiousdiseaseadvisor.com29d
FDA Approves First Generic Version of Victoza for Type 2 Diabetes
According to the Company, the generic product will launch immediately. The Food and Drug Administration (FDA) has approved Liraglutide Injection, the first generic version of Victoza ®. Liraglutide is ...
gastroenterologyadvisor29d
FDA Approves First Generic Liraglutide Once-Daily Injection
HealthDay News — The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), a glucagon-like peptide-1 (GLP-1) receptor agonist ...
U.S. News & World Report1mon
Some GLP-1s Achieve More Weight Loss Than Others: Study
However, a third drug also FDA-approved for weight loss, liraglutide (Saxenda), didn’t work as well as the others, researchers found after reviewing data from dozens of clinical trials.
Autocar Brasil1mon
Mercedes-Benz E-Class review
Topping the range for the time being is the AMG E53, a six-cylinder PHEV. In other regions, there's an E450 petrol as well, but that isn't offered in the UK for the time being - and is unlikely to ...